MediPharm Labs

(OTC: MEDIF)
Healthcare  |  Drug Manufacturers—Specialty & Generic
1.38 0.0 0.0%
Stock Price | June 3, 2020, 3:58 p.m.
1 Follower
Bid: 1.37
Ask: 1.4
Prev. Close: 1.38
52 Week Low: 0.97
52 Week High: 1.7
PE Ratio: 187.454094
Dividend Yield: 0.0%

Company Summary

MediPharm Labs Corp has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulation without first receiving a cannabis cultivation license. The focus on cannabis concentrates from current Good Manufacturing Practices and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to produce purified, pharmaceutical-grade cannabis oil and concentrates for derivative products. The company has invested in the research-driven team, technology, downstream extraction methodologies and purpose-built facilities to deliver safe and precisely-dosed cannabis products to patients and consumers.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Weekend Edition 06/01/20

11 Comments
4 days ago

Premium Cannabis Sub-Sector Review - 05/29/20

6 Comments
4 days ago

Premium Weekly Review 05/29/20

1 Comments
5 days ago

Premium Cannabis Stocks Review - Weekend Edition 05/26/20

39 Comments
1 week ago

Premium Cannabis Sub-Sector Review - 05/22/20

1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 05/21/20

6 Comments
2 weeks ago

Premium Cannabis Stocks Review - Weekend Edition 05/18/20

8 Comments
2 weeks ago

Premium Cannabis Sub-Sector Review - 05/15/20

4 Comments
2 weeks ago

Premium Weekly Review 05/15/20

2 weeks ago

Premium Earnings Previews for the Week Ending 05/15/20 - Part 3

4 Comments
3 weeks ago